Dataset Information

Analysis of performance of clinical biochemistry laboratory using Sigma metrics and Quality Goal Index.

ABSTRACT:

Background

Unreliable and ingenuine results issued by clinical laboratories have serious consequences for the patients. Sigma metrics is a standardized tool for Quality assessment for test performance in a laboratory.

Objective

To evaluate the performance of routine biochemistry laboratory at MMIMSR, Mullana in terms of Sigma metrics and Quality Goal Index.

Material and methods

This cross sectional study evaluated performance of 14 routine chemistry parameters using retrospective Internal Quality Control data of two levels on Siemens Dimension Rxl from Feb to Jul 2019 for CV% and EQAS reports from CMC, Vellore for Bias%. Sigma metrics was calculated using total allowable error targets as per CLIA and Biological Variability database guidelines.

Results

For level-2 IQC; TG, Chol, ALP showed excellent performance with ? ?> ?6 while ? ?< ?3 was observed for AST, Total Protein, Glucose, BUN and ALT using CLIA guidelines while in IQC Level-3 poor performers were only BUN and ALT with Ca, TG and Chol showing ? ?> ?6. Further by using Biological Variability data guidelines; 10 parameters of IQC Level-2 and 5 of IQC level-3 were poor performers with ? ?< ?3.

Conclusion

Sigma metrics is an excellent tool for performance analysis of tests performed in a clinical laboratory. Lack of precision in terms of CV% was seen for majority of the poor performers. Total allowable error targets using Biological Variability data revealed ? ?< ?3 for 10 parameters while using CLIA guidelines ? ?< ?3 was seen for only 5 parameters of IQC level-2.

SUBMITTER: Goel P

PROVIDER: S-EPMC7773579 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Analysis of performance of clinical biochemistry laboratory using Sigma metrics and Quality Goal Index.

Goel Parul P Malik Gagandeep G Prasad Suvarna S Rani Isha I Manhas Sunita S Goel Kapil K

Practical laboratory medicine 20201215

<h4>Background</h4>Unreliable and ingenuine results issued by clinical laboratories have serious consequences for the patients. Sigma metrics is a standardized tool for Quality assessment for test performance in a laboratory.<h4>Objective</h4>To evaluate the performance of routine biochemistry laboratory at MMIMSR, Mullana in terms of Sigma metrics and Quality Goal Index.<h4>Material and methods</h4>This cross sectional study evaluated performance of 14 routine chemistry parameters using retrosp ...[more]

PMID: 33392370

Similar Datasets

Project description:Technical evaluation of swimming performance is an essential factor in preparing elite swimmers for their competitions. Inertial measurement units (IMUs) have attracted much attention recently because they can provide coaches with a detailed analysis of swimmers' performance during training. A coach can obtain a quantitative and objective evaluation from IMU. The purpose of this study was to validate the use of a new phase-based performance assessment with a single IMU worn on the sacrum during training sessions. Sixteen competitive swimmers performed five one-way front crawl trials at their maximum speed wearing an IMU on the sacrum. The coach recorded the lap time for each trial, as it remains the gold standard for swimmer's performance in competition. The measurement was carried out once a week for 10 consecutive weeks to monitor the improvement in the swimmers' performance. Meaningful progress was defined as a time decrease of at least 0.5 s over a 25 m lap. Using validated algorithms, we estimated five goal metrics from the IMU signals representing the swimmer's performance in the swimming phases (wall push-off, glide, stroke preparation, free-swimming) and in the entire lap. The results showed that the goal metrics for free-swimming phase and the entire lap predicted the swimmer's progress well (e.g., accuracy, precision, sensitivity, and specificity of 0.91, 0.89, 0.94, and 0.95 for the lap goal metric, respectively). As the goal metrics for initial phases (wall push-off, glide, stroke preparation) achieved high precision and specificity (≥0.79) in progress detection, the coach can use them for swimmers with satisfactory free-swimming phase performance and make further improvements in initial phases. Changes in the values of the goal metrics have been shown to be correlated with changes in lap time when there is meaningful progress. The results of this study show that goal metrics provided by the phase-based performance evaluation with a single IMU can help monitoring swimming progress. Average velocity of the lap can replace traditional lap time measurement, while phase-based goal metrics provide more information about the swimmer's performance in each phase. This evaluation can help the coach quantitatively monitor the swimmer's performance and train them more efficiently.

Project description:BACKGROUND:This report presents updated National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines summarizing quality requirements for the use of tumor markers. METHODS:One subcommittee developed guidelines for analytical quality relevant to serum and tissue-based tumor markers in current clinical practice. Two other subcommittees formulated recommendations particularly relevant to the developing technologies of microarrays and mass spectrometry. RESULTS:Prerequisites for optimal use of tumor markers in routine practice include formulation of the correct clinical questions to ensure selection of the appropriate test, adherence to good clinical and laboratory practices (e.g., minimization of the risk of incorrect patient and/or specimen identification, tube type, or timing), use of internationally standardized and well-characterized methods, careful adherence to manufacturer instructions, and proactive and timely reactions to information derived from both internal QC and proficiency-testing specimens. Highly desirable procedures include those designed to minimize the risk of the reporting of erroneous results attributable to interferences such as heterophilic antibodies or hook effects, to facilitate the provision of informative clinical reports (e.g., cumulative and/or graphical reports, appropriately derived reference intervals, and interpretative comments), and when possible to integrate these reports with other patient information through electronic health records. Also mandatory is extensive validation encompassing all stages of analysis before introduction of new technologies such as microarrays and mass spectrometry. Provision of high-quality tumor marker services is facilitated by dialogue involving researchers, diagnostic companies, clinical and laboratory users, and regulatory agencies. CONCLUSIONS:Implementation of these recommendations, adapted to local practice, should encourage optimization of the clinical use of tumor markers.

Project description:Formalin-fixed, paraffin-embedded (FFPE) tissues have many advantages for identification of risk biomarkers, including wide availability and potential for extended follow-up endpoints. However, RNA derived from archival FFPE samples has limited quality. Here we identified parameters that determine which FFPE samples have the potential for successful RNA extraction, library preparation, and generation of usable RNAseq data. We optimized library preparation protocols designed for use with FFPE samples using seven FFPE and Fresh Frozen replicate pairs, and tested optimized protocols using a study set of 130 FFPE biopsies from women with benign breast disease. Metrics from RNA extraction and preparation procedures were collected and compared with bioinformatics sequencing summary statistics. Finally, a decision tree model was built to learn the relationship between pre-sequencing lab metrics and qc pass/fail status as determined by bioinformatics metrics.. Samples that failed bioinformatics qc tended to have low median sample-wise correlation within the cohort (Spearman correlation < 0.75), low number of reads mapped to gene regions (< 25 million), or low number of detectable genes (11,400 # of detected genes with TPM > 4). The median RNA concentration and pre-capture library Qubit values for qc failed samples were 18.9 ng/ul and 2.08 ng/ul respectively, which were significantly lower than those of qc pass samples (40.8 ng/ul and 5.82 ng/ul). We built a decision tree model based on input RNA concentration, input library qubit values, and achieved an F score of 0.848 in predicting QC status (pass/fail) of FFPE samples. We provide a bioinformatics quality control recommendation for FFPE samples from breast tissue by evaluating bioinformatic and sample metrics. Our results suggest a minimum concentration of 25 ng/ul FFPE-extracted RNA for library preparation and 1.7 ng/ul pre-capture library output to achieve adequate RNA-seq data for downstream bioinformatics analysis.

Dataset Information

Analysis of performance of clinical biochemistry laboratory using Sigma metrics and Quality Goal Index.

Background

Objective

Material and methods

Results

Conclusion

Publications

Analysis of performance of clinical biochemistry laboratory using Sigma metrics and Quality Goal Index.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets